L193 (Ropinirole Hydrochloride Extended-Release 4 mg)
Pill with imprint L193 is Brown, Capsule-shape and has been identified as Ropinirole hydrochloride extended-release 4 mg. It is supplied by Trigen Laboratories, Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L193
Ropinirole hydrochloride extended-release
- Imprint:
- L193
- Strength:
- 4 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Trigen Laboratories, Inc.
- National Drug Code (NDC):
- 13811-0640
More about ropinirole
- Ropinirole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 230 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Requip, Requip XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
